165 results on '"Jin, Chunmei"'
Search Results
2. Inhibition of MSH6 augments the antineoplastic efficacy of cisplatin in non-small cell lung cancer as autophagy modulator
3. Anti-Toxoplasma gondii agent isolated from Orostachys malacophylla (Pallas) Fischer
4. Chemical constituents from Alnus mandshurica (Callier) Hand.-Mazz. and their chemotaxonomic significance
5. Chemical Constituents of Hylotelephium erythrostictum
6. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae : Data From a Longitudinal Large-scale CRE Study in China (2012–2016)
7. Increased ribosomal protein levels and protein synthesis in the striatal synaptosome of Shank3-overexpressing transgenic mice
8. A new flavonoid from the stem bark of Acer tegmentosum
9. Synthesis and evaluation of novel arctigenin derivatives as potential anti-Toxoplasma gondii agents
10. Emerging roles of Lys63-linked polyubiquitination in neuronal excitatory postsynapses
11. The emerging roles of Shank3 in cardiac function and dysfunction
12. Altered presynaptic function and number of mitochondria in the medial prefrontal cortex of adult Cyfip2 heterozygous mice
13. Transcriptome analysis of Shank3-overexpressing mice reveals unique molecular changes in the hypothalamus
14. Spontaneous seizure and partial lethality of juvenile Shank3-overexpressing mice in C57BL/6 J background
15. Review of: "The Denaturation and Renaturation Kinetics of β-Galactosidase by Chemical Denaturants in The Presence of Galactose, a Product Inhibitor"
16. CYFIP2p. Arg87Cys Causes Neurological Defects and Degradation of CYFIP2
17. Protein interactome and cell‐type expression analyses reveal that cytoplasmic FMR1 ‐interacting protein 1 ( CYFIP1 ), but not CYFIP2 , associates with astrocytic focal adhesion
18. CYFIP2 p.Arg87Cys Causes Neurological Defects and Degradation of CYFIP2.
19. Epidemic Characteristics of Carbapenem-Resistant Klebsiella pneumoniae in the Pediatric Intensive Care Unit of Yanbian University Hospital, China
20. CYFIP2 P.ARG87CYS CAUSES NEUROLOGICAL DEFECTS AND DEGRADATION OF CYFIP2
21. The Neomycin Resistance Cassette in the Targeted Allele of Shank3B Knock-Out Mice Has Potential Off-Target Effects to Produce an Unusual Shank3 Isoform
22. Molecular Characteristics of Carbapenem-Resistant Enterobacter cloacae in a Tertiary Hospital in China
23. Enhanced Prefrontal Neuronal Activity and Social Dominance Behavior in Postnatal Forebrain Excitatory Neuron-Specific Cyfip2 Knock-Out Mice
24. Screening and Verification of Host Proteins Interacting with Neospora Caninum AMA1 Using a Yeast Two-hybrid System
25. Evaluation of ursolic acid derivatives with potential anti-Toxoplasma gondii activity
26. Epilepsy- and intellectual disability-associated CYFIP2 interacts with both actin regulators and RNA-binding proteins in the neonatal mouse forebrain
27. Haploinsufficiency of Cyfip2 Causes Lithium‐Responsive Prefrontal Dysfunction
28. Synthesis, in vitro and in vivo biological evaluation of dihydroartemisinin derivatives with potential anti-Toxoplasma gondii agents
29. Reduced CYFIP2 Stability by Arg87 Variants Causing Human Neurological Disorders
30. Unexpected Compensatory Increase in Shank3 Transcripts in Shank3 Knock-Out Mice Having Partial Deletions of Exons
31. Synthesis and Biological Evaluation of (+)-Usnic Acid Derivatives as Potential Anti-Toxoplasma gondii Agents
32. Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63‐linked polyubiquitin chains
33. Transcriptome analyses suggest minimal effects of Shank3 dosage on directional gene expression changes in the mouse striatum
34. Smaller Body Size, Early Postnatal Lethality, and Cortical Extracellular Matrix-Related Gene Expression Changes of Cyfip2-Null Embryonic Mice
35. The effects of nattokinase supplementation on collagen–epinephrine closure time, prothrombin time and activated partial thromboplastin time in nondiabetic and hypercholesterolemic subjects
36. Retrospective Observational Study from a Chinese Network of the Impact of Combination Therapy versus Monotherapy on Mortality from Carbapenem-Resistant Enterobacteriaceae Bacteremia
37. Correction: The effects of nattokinase supplementation on collagen–epinephrine closure time, prothrombin time and activated partial thromboplastin time in nondiabetic and hypercholesterolemic subjects
38. Synthesis and biological evaluation of ursolic acid derivatives bearing triazole moieties as potential anti-Toxoplasma gondii agents
39. Phenotypic and Genotypic Characterization of Carbapenem-resistantEnterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012–2016)
40. Emerging roles of Lys63-linked polyubiquitination in neuronal excitatory postsynapses
41. Integrative Brain Transcriptome Analysis Reveals Region-Specific and Broad Molecular Changes in Shank3-Overexpressing Mice
42. Molecular Characterization of Carbapenem-Resistant Enterobacter cloacae in 11 Chinese Cities
43. Characterization of the zinc-induced Shank3 interactome of mouse synaptosome
44. Antiparasitic effects of oxymatrine and matrine against Toxoplasma gondii in vitro and in vivo
45. In Vitro and in Vivo Effects of Nitrofurantoin on Experimental Toxoplasmosis
46. Evaluation of Neospora caninum truncated dense granule protein 2 for serodiagnosis by enzyme-linked immunosorbent assay in dogs
47. Molecular Characterization of Carbapenem-Resistant <italic>Enterobacter cloacae</italic> in 11 Chinese Cities.
48. The design, synthesis, and biological evaluation of novel YC-1 derivatives as potent anti-hepatic fibrosis agents
49. Argininosuccinate synthetase gene is silenced by CpG methylation in children with phenylketonuria
50. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.